553
Views
3
CrossRef citations to date
0
Altmetric
Drug Evaluation

Golimumab for the treatment of axial spondyloarthritis

, , , , &
Pages 129-133 | Received 30 Mar 2016, Accepted 31 Oct 2016, Published online: 09 Nov 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ana Teresa Melo, Raquel Campanilho-Marques & João Eurico Fonseca. (2021) Golimumab (anti-TNF monoclonal antibody): where we stand today. Human Vaccines & Immunotherapeutics 17:6, pages 1586-1598.
Read now

Articles from other publishers (2)

Salvatore D’Angelo, Enrico Tirri, Angela Maria Giardino, Marco Mattucci-Cerinic, Lorenzo Dagna, Leonardo Santo, Francesco Ciccia, Bruno Frediani, Marcello Govoni, Francesca Bobbio Pallavicini, Rosa Daniela Grembiale, Andrea Delle Sedie, Rita Mulè, Francesco Paolo Cantatore, Rosario Foti, Elisa Gremese, Paola Conigliaro, Fausto Salaffi, Ombretta Viapiana, Alberto Cauli, Roberto Giacomelli, Luisa Arcarese, Giuliana Guggino, Romualdo Russo, Amy Puenpatom, Domenico Capocotta, Francesca Nacci, Maria Grazia Anelli, Valentina Picerno, Corrado Binetti & Florenzo Iannone. (2022) Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study. Journal of Clinical Medicine 11:14, pages 4178.
Crossref
Servet Akar, Umut Kalyoncu, Ediz Dalkilic, Hakan Emmungil, Ayten Aziz, Yasemin Esen & Tuba Koc. (2021) GO-BEYOND: a real-world study of persistence of golimumab in patients with axial spondyloarthritis and rheumatoid arthritis in Turkey. Immunotherapy 13:10, pages 841-850.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.